How Can Early-Stage Medical Device Companies Survive Market Turmoil?
David Hochman, founder and CEO of Orchestra BioMed, shares how the company’s risk-reward sharing business model has helped it stay afloat during the coronavirus pandemic.
How Can Early-Stage Medical Device Companies Survive Market Turmoil? Read More »